Prelude Capital Management’s Juno Therapeutics, Inc. JUNO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2017
Q4
Sell
-23,649
Closed -$1.06M 1794
2017
Q3
$1.06M Buy
23,649
+15,071
+176% +$676K 0.1% 200
2017
Q2
$256K Sell
8,578
-1,922
-18% -$57.4K 0.02% 453
2017
Q1
$233K Buy
10,500
+5,456
+108% +$121K 0.02% 477
2016
Q4
$95K Buy
5,044
+5,024
+25,120% +$94.6K 0.01% 820
2016
Q3
$1K Sell
20
-480
-96% -$24K ﹤0.01% 1480
2016
Q2
$19K Buy
500
+200
+67% +$7.6K ﹤0.01% 1244
2016
Q1
$11K Buy
+300
New +$11K ﹤0.01% 1089
2015
Q3
Sell
-500
Closed -$27K 1886
2015
Q2
$27K Buy
+500
New +$27K ﹤0.01% 1215